We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

71 hedge funds and large institutions have $285M invested in Korro Bio in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

57% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 14

11% more funds holding

Funds holding: 64 → 71 (+7)

0.79% more ownership

Funds ownership: 91% → 91.8% (+0.79%)

0% less capital invested

Capital invested by funds: $286M → $285M (-$416K)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
71
Holders Change
+7
Holders Change %
+10.94%
% of All Funds
1.02%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
15
Increased
22
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SSA
Schonfeld Strategic Advisors
New York
+$4.31M
2
DTC
Deep Track Capital
Connecticut
+$3.34M
3
BlackRock
BlackRock
New York
+$1.83M
4
Northern Trust
Northern Trust
Illinois
+$1.79M
5
ACM
ADAR1 Capital Management
Texas
+$1.78M

Top Sellers

1
AG
Artal Group
Luxembourg
-$14M
2
EAM
Eventide Asset Management
Massachusetts
-$5.81M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.51M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.32M
5
Verition Fund Management
Verition Fund Management
Connecticut
-$1.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$38M – – –
NMC
2
NEA Management Company
Maryland
$36.5M – – –
DTC
3
Deep Track Capital
Connecticut
$28.4M +$3.34M +79,355 +10%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$19.4M -$2.51M -59,562 -9%
Citadel Advisors
5
Citadel Advisors
Florida
$17.7M – – –
BlackRock
6
BlackRock
New York
$15M +$1.83M +43,569 +11%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$14.9M -$473K -11,235 -2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$14.6M -$1.32M -31,442 -7%
SL
9
Siren LLC
Connecticut
$14M +$17.6M +418,833 New
EAM
10
Eventide Asset Management
Massachusetts
$13.1M -$5.81M -137,989 -26%
QUSVM
11
Qiming U.S. Ventures Management
Washington
$12.3M – – –
7IH
12
72 Investment Holdings
Connecticut
$9.25M – – –
CAM
13
Cormorant Asset Management
Massachusetts
$8.88M – – –
DCM
14
Driehaus Capital Management
Illinois
$5.16M +$1.58M +37,637 +32%
SSA
15
Schonfeld Strategic Advisors
New York
$4.77M +$4.31M +102,342 +254%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$4.6M -$90.9K -2,161 -2%
State Street
17
State Street
Massachusetts
$3.97M +$794K +18,877 +19%
GTC
18
Ghost Tree Capital
New York
$3.68M +$421K +10,000 +10%
Verition Fund Management
19
Verition Fund Management
Connecticut
$3.12M -$1.22M -29,095 -24%
Millennium Management
20
Millennium Management
New York
$2.41M -$502K -11,940 -14%
TLP
21
Tri Locum Partners
New York
$2.14M -$312K -7,414 -10%
Northern Trust
22
Northern Trust
Illinois
$1.93M +$1.79M +42,548 +278%
ACM
23
ADAR1 Capital Management
Texas
$1.65M +$1.78M +42,241 +586%
ECM
24
ExodusPoint Capital Management
New York
$1.38M -$617K -14,671 -26%
RSCM
25
Rock Springs Capital Management
Maryland
$1.19M – – –
1
2 3 4

KRRO Hedge Fund Activity: Q3 2024 in Review

71 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2024, worth a combined $285M — down 0.15% from $286M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new KRRO positions and 8 closed out — a net gain of 7 holders — while 22 added to existing stakes and 14 trimmed.

The largest buyer was Schonfeld Strategic Advisors, adding an estimated $4.31M. The largest seller was Artal Group, exiting entirely with an estimated $14M sold.

  • 71 institutional investors held Korro Bio (KRRO) as of Q3 2024, up from 64 in Q2 2024.
  • Funds reported $285M of Korro Bio stock for Q3 2024, down 0.15% quarter-over-quarter.
  • 15 funds opened new Korro Bio positions in Q3 2024 and 8 closed out, a net change of +7 holders.
  • The largest Korro Bio buyer in Q3 2024 was Schonfeld Strategic Advisors, an estimated $4.31M added.
  • The largest Korro Bio seller in Q3 2024 was Artal Group, an estimated $14M sold.

Based on aggregated 13F filings for Q3 2024.